Author:
Higuchi Tomoaki,Takagi Kae,Tochimoto Akiko,Ichimura Yuki,Norose Takanari,Katsumata Yasuhiro,Masuda Ikuko,Yamanaka Hisashi,Morohoshi Toshiro,Kawaguchi Yasushi
Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Gabrielli A, Avvedimento EV, Krieg T. Mechanisms of disease: scleroderma. N Engl J Med. 2009;360:1989–2003.
2. Jinnin M. Mechanisms of skin fibrosis in systemic sclerosis. J Dermatol. 2010;37:11–25.
3. Kataoka H, Yasuda S, Fukaya S, Oku K, Horita T, Atsumi T, Koike T. Decreased expression of Runx1 and lowered proportion of Foxp3+ CD25+ CD4+ regulatory T cells in systemic sclerosis. Mod Rheumatol. 2015;25:90–5.
4. Kuwana M, Sato S, Kikuchi K, Kawaguchi Y, Fujisaku A, Misaki Y, et al. Evaluation of functional disability using the health assessment questionnaire in Japanese patients with systemic sclerosis. J Rheumatol. 2003;30:1253–8.
5. Iudici M. What should clinicians know about the use of glucocorticoids in systemic sclerosis? Mod Rheumatol. 2017;6:1–5.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献